vs
COLLEGIUM PHARMACEUTICAL, INC（COLL）与Forestar Group Inc.（FOR）财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是COLLEGIUM PHARMACEUTICAL, INC的1.3倍（$273.0M vs $205.4M），COLLEGIUM PHARMACEUTICAL, INC净利率更高（8.3% vs 5.6%，领先2.6%），COLLEGIUM PHARMACEUTICAL, INC同比增速更快（12.9% vs 9.0%），COLLEGIUM PHARMACEUTICAL, INC自由现金流更多（$122.4M vs $-157.1M），过去两年COLLEGIUM PHARMACEUTICAL, INC的营收复合增速更高（19.1% vs -9.6%）
Collegium制药是一家专科制药企业，专注于研发和商业化具备滥用威慑特性的创新疼痛管理疗法，主要面向美国市场，推出适用于慢性疼痛患者的缓释镇痛产品，服务覆盖基层及专科医疗领域的医护人员。
福雷斯特集团是一家住宅地块开发企业，总部位于得克萨斯州阿灵顿，业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内，该公司交付了11518块住宅地块，目前在纽约证券交易所上市，自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
COLL vs FOR — 直观对比
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $205.4M | $273.0M |
| 净利润 | $17.0M | $15.4M |
| 毛利率 | 62.5% | 20.1% |
| 营业利润率 | 29.6% | 7.6% |
| 净利率 | 8.3% | 5.6% |
| 营收同比 | 12.9% | 9.0% |
| 净利润同比 | 35.3% | -6.7% |
| 每股收益（稀释后） | $0.48 | $0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $205.4M | $273.0M | ||
| Q3 25 | $209.4M | $670.5M | ||
| Q2 25 | $188.0M | $390.5M | ||
| Q1 25 | $177.8M | $351.0M | ||
| Q4 24 | $181.9M | $250.4M | ||
| Q3 24 | $159.3M | $551.3M | ||
| Q2 24 | $145.3M | $318.4M | ||
| Q1 24 | $144.9M | $333.8M |
| Q4 25 | $17.0M | $15.4M | ||
| Q3 25 | $31.5M | $86.9M | ||
| Q2 25 | $12.0M | $32.9M | ||
| Q1 25 | $2.4M | $31.6M | ||
| Q4 24 | $12.5M | $16.5M | ||
| Q3 24 | $9.3M | $81.5M | ||
| Q2 24 | $19.6M | $38.7M | ||
| Q1 24 | $27.7M | $45.0M |
| Q4 25 | 62.5% | 20.1% | ||
| Q3 25 | 61.7% | 22.3% | ||
| Q2 25 | 57.7% | 20.4% | ||
| Q1 25 | 54.8% | 22.6% | ||
| Q4 24 | 54.0% | 22.0% | ||
| Q3 24 | 60.8% | 23.9% | ||
| Q2 24 | 62.5% | 22.5% | ||
| Q1 24 | 63.1% | 24.9% |
| Q4 25 | 29.6% | 7.6% | ||
| Q3 25 | 29.7% | 16.9% | ||
| Q2 25 | 18.7% | 11.2% | ||
| Q1 25 | 12.2% | 11.6% | ||
| Q4 24 | 20.9% | 8.7% | ||
| Q3 24 | 21.9% | 19.7% | ||
| Q2 24 | 32.7% | 16.2% | ||
| Q1 24 | 34.1% | 17.6% |
| Q4 25 | 8.3% | 5.6% | ||
| Q3 25 | 15.0% | 13.0% | ||
| Q2 25 | 6.4% | 8.4% | ||
| Q1 25 | 1.4% | 9.0% | ||
| Q4 24 | 6.9% | 6.6% | ||
| Q3 24 | 5.9% | 14.8% | ||
| Q2 24 | 13.5% | 12.2% | ||
| Q1 24 | 19.1% | 13.5% |
| Q4 25 | $0.48 | $0.30 | ||
| Q3 25 | $0.84 | $1.70 | ||
| Q2 25 | $0.34 | $0.65 | ||
| Q1 25 | $0.07 | $0.62 | ||
| Q4 24 | $0.36 | $0.32 | ||
| Q3 24 | $0.27 | $1.59 | ||
| Q2 24 | $0.52 | $0.76 | ||
| Q1 24 | $0.71 | $0.89 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $386.7M | $211.7M |
| 总债务越低越好 | — | $793.2M |
| 股东权益账面价值 | $301.7M | $1.8B |
| 总资产 | $1.7B | $3.2B |
| 负债/权益比越低杠杆越低 | — | 0.44× |
8季度趋势，按日历期对齐
| Q4 25 | $386.7M | $211.7M | ||
| Q3 25 | $285.9M | $379.2M | ||
| Q2 25 | $222.2M | $189.2M | ||
| Q1 25 | $197.8M | $174.3M | ||
| Q4 24 | $162.8M | $132.0M | ||
| Q3 24 | $120.0M | $481.2M | ||
| Q2 24 | $271.6M | $359.2M | ||
| Q1 24 | $318.0M | $416.2M |
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
| Q4 25 | $301.7M | $1.8B | ||
| Q3 25 | $274.8M | $1.8B | ||
| Q2 25 | $232.2M | $1.7B | ||
| Q1 25 | $234.4M | $1.6B | ||
| Q4 24 | $228.8M | $1.6B | ||
| Q3 24 | $234.3M | $1.6B | ||
| Q2 24 | $216.6M | $1.5B | ||
| Q1 24 | $222.2M | $1.5B |
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.6B | $3.1B | ||
| Q2 25 | $1.6B | $3.1B | ||
| Q1 25 | $1.6B | $3.0B | ||
| Q4 24 | $1.7B | $3.0B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.1B | $2.7B | ||
| Q1 24 | $1.1B | $2.6B |
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.0M | $-157.0M |
| 自由现金流经营现金流 - 资本支出 | $122.4M | $-157.1M |
| 自由现金流率自由现金流/营收 | 59.6% | -57.5% |
| 资本支出强度资本支出/营收 | 0.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 7.25× | -10.19× |
| 过去12个月自由现金流最近4个季度 | $327.6M | $93.0M |
8季度趋势，按日历期对齐
| Q4 25 | $123.0M | $-157.0M | ||
| Q3 25 | $78.4M | $256.3M | ||
| Q2 25 | $72.4M | $15.8M | ||
| Q1 25 | $55.4M | $-19.8M | ||
| Q4 24 | $84.6M | $-450.0M | ||
| Q3 24 | $-9.0M | $119.2M | ||
| Q2 24 | $67.4M | $-61.7M | ||
| Q1 24 | $61.9M | $-59.2M |
| Q4 25 | $122.4M | $-157.1M | ||
| Q3 25 | $78.3M | $255.6M | ||
| Q2 25 | $72.4M | $15.0M | ||
| Q1 25 | $54.6M | $-20.5M | ||
| Q4 24 | $84.1M | — | ||
| Q3 24 | $-9.2M | $118.4M | ||
| Q2 24 | $67.1M | $-62.3M | ||
| Q1 24 | $61.4M | $-59.8M |
| Q4 25 | 59.6% | -57.5% | ||
| Q3 25 | 37.4% | 38.1% | ||
| Q2 25 | 38.5% | 3.8% | ||
| Q1 25 | 30.7% | -5.8% | ||
| Q4 24 | 46.2% | — | ||
| Q3 24 | -5.8% | 21.5% | ||
| Q2 24 | 46.2% | -19.6% | ||
| Q1 24 | 42.3% | -17.9% |
| Q4 25 | 0.3% | 0.0% | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.4% | 0.2% | ||
| Q4 24 | 0.3% | 0.0% | ||
| Q3 24 | 0.2% | 0.1% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 0.4% | 0.2% |
| Q4 25 | 7.25× | -10.19× | ||
| Q3 25 | 2.49× | 2.95× | ||
| Q2 25 | 6.05× | 0.48× | ||
| Q1 25 | 22.92× | -0.63× | ||
| Q4 24 | 6.75× | -27.27× | ||
| Q3 24 | -0.96× | 1.46× | ||
| Q2 24 | 3.44× | -1.59× | ||
| Q1 24 | 2.23× | -1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COLL
暂无分部数据
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
